Future research in TCC is focused on understanding the molecular mechanisms underlying the disease, developing novel biomarkers for early detection, and improving therapeutic options. Advances in genomics and personalized medicine hold promise for more targeted treatments that can improve outcomes and reduce side effects. Additionally, ongoing studies aim to explore the role of the microbiome in bladder cancer development and response to treatment.
